This newsletter presents you the following key sessions:
1. Podcast with dr. Wainberg about the updated results from the phase III Keynote-062 trial
2. Lenvatinib plus transarterial chemoembolisation improves clinical outcomes in patients with advanced
hepatocellular carcinoma
3. Adjuvant chemotherapy with S-1 as a novel standard of care for curatively resected biliary tract cancer
4. Overall survival benefit with trastuzumab deruxtecan in previously treated HER2-positive gastric cancer
5. First-line pembrolizumab plus chemotherapy as a standard of care in advanced oesophageal cancer